Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
61 studies found for:    Open Studies | "Diabetic Nephropathies"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Diabetic Nephropathies"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Glutathione in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Proteinuria;   Oxidative Stress
Interventions: Drug: N-acetylcysteine placebo + silibin placebo;   Drug: N-acetylcysteine active + silibin placebo;   Drug: N-acetylcysteine placebo + silibin active;   Drug: N-acetylcysteine active + silibin active;   Drug: N-acetylcysteine active + high-dose silibin active
2 Recruiting Renal Denervation in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Persistent Proteinuria With Type II Diabetes
Interventions: Procedure: Percutaneous renal denervation and TMNS;   Drug: Standardized antiproteinuric medication regimen includes an angiotensin receptor blocker , a diuretic , 25OH vitamin D3 and a statin
3 Unknown  Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease
Intervention: Drug: Mycophenolate Mofetil (MMF) ,phosphodiesterase 5 inhibitors , CARNITINE
4 Recruiting N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
Conditions: Diabetic Nephropathies;   Proteinuria;   Oxidative Stress
Interventions: Dietary Supplement: N-acetylcysteine;   Dietary Supplement: silibin;   Dietary Supplement: high-dose silibin;   Dietary Supplement: N-acetylcysteine placebo;   Dietary Supplement: silibin placebo
5 Not yet recruiting The Significance of Urine UbA52 In the Diagnosis of Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention:
6 Recruiting Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients
Condition: Diabetic Nephropathy
Interventions: Drug: Repository Corticotropin Injection;   Drug: Placebo
7 Recruiting Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: MT-3995;   Drug: Placebo
8 Unknown  Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study
Conditions: Diabetes;   Diabetic Nephropathy;   Renal Protection
Intervention: Drug: Rosiglitasone (retrospective observation)
9 Recruiting Pyridorin in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Diabetic Kidney Disease
Interventions: Drug: Pyridorin;   Drug: Placebo
10 Recruiting Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
Conditions: Diabetic Nephropathy;   Diabetic Retinopathy
Interventions: Drug: Spironolactone;   Drug: Placebo;   Drug: Standard care
11 Recruiting Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy
Conditions: Diabetes Mellitus, Type 2;   Diabetic Nephropathies
Interventions: Drug: Canagliflozin;   Drug: Placebo
12 Recruiting Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy
Conditions: Diabetes Type 2;   Diabetic Nephropathy;   Vascular Disease
Interventions: Drug: Ramipril;   Drug: Clopidogrel
13 Recruiting Mechanisms of Diabetic Kidney Disease in American Indians
Conditions: Nervous System;   Diabetic Kidney Disease;   Diabetes Mellitus, Type 2
Intervention:
14 Recruiting Validation of Biomarkers of Diabetic Nephropathy in Type I Diabetic Children
Condition: Type 1 Diabetes Mellitus With Diabetic Nephropathy
Intervention: Other: Urinary sample collection
15 Recruiting Colchicine for Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: colchicine
16 Unknown  Aldosterone in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Spironolactone;   Drug: Placebo
17 Not yet recruiting Using a Diabetic Kidney Disease (DKD) Registry to Treat to Multiple Targets (TMT)
Condition: Diabetic Kidney Disease
Interventions: Other: Telephone Reminder;   Other: Doctor-Nurse Follow Up;   Other: Personalized Risk Report for Patient Empowerment
18 Recruiting Study Of Diabetic Nephropathy With Atrasentan
Condition: Diabetic Nephropathy
Interventions: Drug: Atrasentan;   Drug: Placebo
19 Recruiting Study of LY3016859 in Participants With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Placebo;   Drug: LY3016859
20 Recruiting Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Beraprost sodium

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years